The real purpose of Serotonine

Serotonin · Gut · Bone · Mood
nammu.academy
The Real Functions of Serotonin

Mostly Not in Your Head.
What Serotonin Is Actually Doing, Almost All of It Somewhere Else.

Serotonin is described as the happiness chemical. Around 90 to 95 percent of it is not in your brain, it cannot get into your brain, and where it is, it does entirely different jobs: gut motility, blood clotting, bone formation, liver regeneration. This post is about the other ninety-five percent, and what it does to the story you were told.

nammu.academy
3 interactive sections
10 peer-reviewed sources
~90-95%Of body serotonin in the gut, not the brain
ZeroSerotonin that crosses the blood brain barrier
52%Higher brain synthesis rate measured in men than in women
OppositeEffects of serotonin on bone, depending on where it is made

Two facts, put next to each other, dismantle most of what gets said about serotonin.

The first: the overwhelming majority of the serotonin in your body, on the order of ninety to ninety-five percent, is made and held in the gut, by enterochromaffin cells in the lining of the intestine. [1][2]

The second: serotonin does not cross the blood brain barrier. Its precursor, the amino acid tryptophan, does. Serotonin itself does not. [3]

Those two facts together mean the body runs two separate serotonin systems that cannot reach each other. A large peripheral one, doing things that have nothing to do with mood. A small central one, made locally in the brain from tryptophan that arrived through the barrier.

Which is why a banana cannot raise your brain serotonin, and why a serotonin supplement would be pharmacologically inert in the place people want it to work.

What interests me is not the debunk. It is what the other ninety-five percent is actually doing, because the answer turns out to include bone density and liver regeneration and blood clotting, and almost nobody who takes a serotonergic drug has been told any of it.

Where It Is, and What It Does There

Approximate distribution, and five entirely different jobs. Tap a band or a tab.

Distribution figures are the widely reported approximations from the gut serotonin literature, not precise measurements. The functions are individually sourced below. [1][2][4][5][6][7]

The impermeability is the structural fact that everything else in this post depends on, so it is worth being precise about what does and does not get through.

Tryptophan crosses. It is an essential amino acid, carried across the blood brain barrier by a transporter it shares with several other large neutral amino acids, which means those amino acids compete with it for passage. Once inside, neurons convert it to 5-hydroxytryptophan and then to serotonin locally. [3]

Serotonin does not. The molecule circulating in your blood, the vast majority of which came from your gut and is stored in platelets, stays on the peripheral side. It is not a pool the brain can draw on. [3]

Which is what makes tryptophan depletion such a useful experiment. Because the brain has to make its own serotonin continuously from imported tryptophan, you can lower brain serotonin synthesis within hours by giving someone an amino acid mixture that contains everything except tryptophan. This is the standard experimental tool for asking what lowered brain serotonin actually does. [3][10]

Two
Separate serotonin systems, in one body, that cannot exchange molecules. Almost every popular claim about serotonin collapses the moment you keep them apart.

What Gets Through

Four things people take to raise serotonin. Only some of them can reach the brain at all.

Crossing the barrier is necessary for a central effect, and not sufficient. A molecule that gets in still has to do something once it is there. [3]

If I had to pick one result to show that serotonin is not a mood molecule with side jobs, it would be this one.

Serotonin has opposite effects on bone depending on where it was made. Patricia Ducy and Gerard Karsenty describe a molecule synthesised by two different genes at two different sites, performing antagonistic functions on bone mass at each. Made peripherally, in the gut, serotonin acts as a hormone that inhibits bone formation. Made in the brain, it acts as a neurotransmitter with a positive and dominant effect on bone mass, increasing formation and limiting resorption. [6]

The finding that opened it up. Vijay Yadav and colleagues showed that the gene Lrp5, long known to control bone mass, does so by inhibiting serotonin synthesis in the duodenum. A bone gene, working through the gut, via serotonin. [5]

And one from a different organ entirely. Mickael Lesurtel and colleagues showed that platelet-derived serotonin is required for liver regeneration in mice. Animals lacking peripheral serotonin failed to regenerate liver tissue properly, and the defect was rescued by restoring serotonin. [7]

Bone formation. Liver regeneration. Gut motility. Haemostasis. This is not a happiness chemical with a few unrelated duties. It is an ancient signalling molecule that the nervous system borrowed comparatively late, for a small fraction of the total.

The same molecule inhibits bone formation from the gut and promotes it from the brain. Any sentence that begins "serotonin makes you" is already wrong.

The Serotonin Theory of Depression, Audited

Six research areas, reviewed in one umbrella review. Tap each to expand.

Moncrieff and colleagues, systematic umbrella review. The review is contested; the last panel is not optional reading. [8][9]

There is a sex difference in this system that is much larger than most sex differences in neuroscience, and it has been sitting in the literature since 1997.

Men's brains were measured synthesising serotonin 52 percent faster than women's. Sukhwinder Nishizawa, Chawki Benkelfat, Simon Young and colleagues used positron emission tomography to measure rates of serotonin synthesis in the human brain, and found the mean rate in normal males was 52 percent higher than in normal females. The authors themselves raised the possibility that this is relevant to the lower incidence of major unipolar depression in men. [10]

They also noted something that matters for how the whole field works: rates of synthesis are relatively uniform across brain regions, unlike serotonin levels, which vary a great deal. So this is a difference in the production line rather than in one location. [10]

Sample sizes in PET studies of this era were small and this specific figure has been debated since. But the direction has held up across the tryptophan depletion literature, where lowering tryptophan tends to produce larger mood effects in women than in men.

The part that should make you angry

The chemical imbalance was explained to women more than to anyone, and the bone half was never mentioned.

Two things bother me here and they point in opposite directions, which is why I am not going to resolve them for you.

The first. Women are prescribed antidepressants at substantially higher rates than men, and the explanation most often supplied with the prescription was a serotonin deficiency. The umbrella review found no consistent evidence that depression is caused by lowered serotonin concentration or activity. [8] Whatever you think of that review, and it has been vigorously contested, the honest position is that the explanation given to millions of women was firmer in the consulting room than it ever was in the literature.

The second, which cuts the other way. That does not mean the drugs do not work. Cipriani and colleagues' network meta-analysis of 21 antidepressants found all of them more effective than placebo for acute major depression in adults. [9] A treatment can work without the story attached to it being true, and aspirin worked for decades before anyone knew about prostaglandins. Nothing here is a reason to stop taking something that is helping you, and stopping abruptly is its own harm.

What I do want named is the omission. Peripheral serotonin inhibits bone formation. [5][6] The population prescribed serotonergic drugs most often is also the population at highest lifetime risk of osteoporosis and fragility fracture, for reasons involving oestrogen withdrawal at menopause. Those two facts belong in the same conversation, and the interaction between them is not well characterised, partly because women's skeletal outcomes and women's mood treatment sit in separate specialties that do not read each other.

And underneath both: a 52 percent sex difference in brain serotonin synthesis, published in 1997, in the system that the most-prescribed psychiatric drug class targets. [10] Ask how much of the dosing, trial design and mechanistic research since then has treated that as a central variable rather than a footnote.

Where the evidence gets thin

Four things to hold lightly

The ninety to ninety-five percent figure is an approximation that circulates in the gut serotonin literature rather than a precisely measured constant, and the exact fraction depends on what you count and how. The qualitative point, that the overwhelming majority is peripheral, is not in dispute. [1][2]

Most of the bone work is in mice, including the genetic manipulations that established the two-site model. Human data on peripheral serotonin and bone density is thinner and more mixed than the mechanistic story suggests. [5][6]

The umbrella review is genuinely contested. Critics argue it tested a simplified version of the serotonin hypothesis that the field had already moved past, and that absence of a consistent deficiency signal in these particular research areas does not settle serotonin's role in depression. I have cited it because it is the most systematic attempt at the question, not because it closes it. [8]

And nothing in this post is advice about medication. If you are taking an SSRI, this is background about a molecule, not a reason to change anything. Decisions about antidepressants involve your history, your symptoms and withdrawal risk, and belong with your prescriber. [9]

01
Stop buying serotoninIt cannot get where you want it

Serotonin taken orally does not reach the brain, and food serotonin does not either. The bananas story, the walnuts story, any claim built on the serotonin content of a food, fails at the barrier. Tryptophan and 5-HTP do cross, which is a separate question with its own risks. [3]

02
Take gut symptoms seriously as gut symptomsNot as mood leaking downwards

The gut runs the largest serotonin system in the body and uses it for motility and secretion, which is why serotonergic drugs target the gut directly in functional bowel disorders. Your gut is not expressing your feelings; it is running its own signalling system that happens to use the same molecule. [1][2]

03
If you take an SSRI long term, ask about boneA question, not a warning

Given what peripheral serotonin does to bone formation, and given who is prescribed these drugs, bone density is a reasonable thing to raise with a doctor over years of use, especially around and after menopause. That is a conversation to have, not a reason to stop anything. [5][6]

04
Notice when a molecule gets a personalityIt is always a simplification with something behind it

Happiness chemical, stress hormone, love hormone. Every one of these labels takes a molecule with many jobs across many tissues and assigns it one feeling, which makes it sellable. Serotonin is the clearest case, because the label describes about five percent of the total.

You asked the question that gets to the heart of it: over ninety percent of it is not being used in the brain and cannot cross the barrier. That is correct, and following it properly changes the picture rather than just correcting a detail.

Serotonin is old. It regulates gut movement in animals with no brain worth speaking of. By the time vertebrate nervous systems started using it as a neurotransmitter, it had already been doing peripheral signalling work for a very long time, which is why it shows up in bone, liver, blood and gut with functions that have nothing to do with each other and in one case directly oppose each other across two sites in the same animal.

The happiness chemical framing took the smallest compartment, gave it the whole molecule's name, and sold it back to us. It also gave a generation of women an explanation for their own distress that was tidier than the evidence ever was, while never mentioning that the same molecule, in the compartment that holds almost all of it, is quietly telling their bones to stop building.

None of which makes serotonin less interesting. It makes it much more interesting, and considerably less obedient to a story.

Molecules that get simplified into feelings, and the specific cost of that simplification for women, is a thread running through The Art of Female Health. The chapter on hormonal storytelling covers the same failure mode in oestrogen and cortisol. nammu.academy/book

Ninety-five percent of it is somewhere else. Love, Nina ❤

References

  1. Gershon, M. D., & Tack, J. (2007). The serotonin signaling system: From basic understanding to drug development for functional GI disorders. Gastroenterology, 132(1), 397–414. https://doi.org/10.1053/j.gastro.2006.11.002
  2. Mawe, G. M., & Hoffman, J. M. (2013). Serotonin signalling in the gut: Functions, dysfunctions and therapeutic targets. Nature Reviews Gastroenterology & Hepatology, 10(8), 473–486. https://doi.org/10.1038/nrgastro.2013.105
  3. Jenkins, T. A., Nguyen, J. C. D., Polglaze, K. E., & Bertrand, P. P. (2016). Influence of tryptophan and serotonin on mood and cognition with a possible role of the gut-brain axis. Nutrients, 8(1), 56. https://doi.org/10.3390/nu8010056
  4. Yano, J. M., Yu, K., Donaldson, G. P., et al. (2015). Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell, 161(2), 264–276. https://doi.org/10.1016/j.cell.2015.02.047
  5. Yadav, V. K., Ryu, J.-H., Suda, N., et al. (2008). Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum. Cell, 135(5), 825–837. https://doi.org/10.1016/j.cell.2008.09.059
  6. Ducy, P., & Karsenty, G. (2010). The two faces of serotonin in bone biology. Journal of Cell Biology, 191(1), 7–13. https://doi.org/10.1083/jcb.201006123
  7. Lesurtel, M., Graf, R., Aleil, B., et al. (2006). Platelet-derived serotonin mediates liver regeneration. Science, 312(5770), 104–107. https://doi.org/10.1126/science.1123842
  8. Moncrieff, J., Cooper, R. E., Stockmann, T., Amendola, S., Hengartner, M. P., & Horowitz, M. A. (2023). The serotonin theory of depression: A systematic umbrella review of the evidence. Molecular Psychiatry, 28(8), 3243–3256. https://doi.org/10.1038/s41380-022-01661-0
  9. Cipriani, A., Furukawa, T. A., Salanti, G., et al. (2018). Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: A systematic review and network meta-analysis. The Lancet, 391(10128), 1357–1366. https://doi.org/10.1016/S0140-6736(17)32802-7
  10. Nishizawa, S., Benkelfat, C., Young, S. N., et al. (1997). Differences between males and females in rates of serotonin synthesis in human brain. PNAS, 94(10), 5308–5313. https://doi.org/10.1073/pnas.94.10.5308
nammu.academy  ·  Mostly Not in Your Head  ·  All sources peer-reviewed & DOI-verified
Next
Next

Sleep side